[The treatment of hepatoses].
D001711:Biotransformation; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy*; D002779:Cholestasis / Q000628:therapy; D004035:Diet Therapy; D005234:Fatty Liver / Q000188:drug therapy / Q000628:therapy*; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008082:Lipotropic Agents / Q000009:adverse effects / Q000627:therapeutic use; D008107:Liver Diseases / Q000188:drug therapy / Q000628:therapy*; D009963:Orotic Acid / Q000009:adverse effects / Q000627:therapeutic use; D010743:Phospholipids / Q000627:therapeutic use; D014815:Vitamins / Q000009:adverse effects / Q000627:therapeutic use
D005938:Glucocorticoids; D008082:Lipotropic Agents; D010743:Phospholipids; D014815:Vitamins; D009963:Orotic Acid
Die Behandlung der Hepatosen.